Vycor Medical (VYCO) EBIT Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Vycor Medical | - | - | 375,153.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7,993.00 |
| Dec 31, 2025 | 5,124.00 |
| Sep 30, 2025 | 8,104.00 |
| Jun 30, 2025 | 9,192.00 |
| Mar 31, 2025 | 4,148.00 |
| Dec 31, 2024 | 5,430.00 |
| Sep 30, 2024 | 4,232.00 |
| Jun 30, 2024 | 3,568.00 |
| Mar 31, 2024 | 4,361.00 |
| Dec 31, 2023 | 8,824.00 |
| Sep 30, 2023 | 2,084.00 |
| Jun 30, 2023 | 15,446.00 |
| Mar 31, 2023 | 10,595.00 |
| Dec 31, 2022 | 10,105.00 |
| Sep 30, 2022 | 4,958.00 |
| Jun 30, 2022 | 9,234.00 |
| Mar 31, 2022 | 5,311.00 |
| Dec 31, 2021 | 7,525.00 |
| Sep 30, 2021 | 7,014.00 |
| Jun 30, 2021 | 8,161.00 |
| Mar 31, 2021 | 5,873.00 |
| Dec 31, 2020 | 8,773.00 |
| Sep 30, 2020 | 13,486.00 |
| Jun 30, 2020 | 7,855.00 |
| Mar 31, 2020 | 14,074.00 |
| Sep 30, 2019 | 7,963.00 |
| Jun 30, 2019 | 20,399.00 |
| Mar 31, 2019 | 23,071.00 |
| Dec 31, 2018 | 8,627.00 |
| Sep 30, 2018 | 12,145.00 |
| Jun 30, 2018 | 12,499.00 |
| Mar 31, 2018 | 16,207.00 |
| Dec 31, 2017 | 4,957.00 |
| Sep 30, 2017 | 26,836.00 |
| Jun 30, 2017 | 16,485.00 |
| Mar 31, 2017 | 10,571.00 |
| Dec 31, 2016 | 4,146.00 |
| Sep 30, 2016 | 38,336.00 |
| Jun 30, 2016 | 119,184.00 |
| Mar 31, 2016 | 49,962.00 |
| Dec 31, 2015 | 65,567.00 |
| Sep 30, 2015 | 27,856.00 |
| Jun 30, 2015 | 38,569.00 |